Samco Large & Mid Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly Large Cap and Mid Cap equity and equity-related securities.
Growthvine rating: 1/5 — ranked #40 of 41 in category.
Fund basics
| Category | Equity: Large & Mid Cap |
|---|
| NAV | ₹8.42 (as of 2026-10-23) |
|---|
| AUM | ₹99 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dhawal Ghanshyam Dhanani |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −17.37% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 37.2% of NIFTY LargeMidcap 250's upside and 95.1% of its downside.
Market cap allocation
| Large cap | 49.2% |
|---|
| Mid cap | 39.3% |
|---|
| Small cap | 11.5% |
|---|
Concentration
| Top 5 holdings | 30.8% |
|---|
| Top 10 holdings | 46.6% |
|---|
| Total holdings | 61 |
|---|
| Index overlap | 13.4% |
|---|
| Active share | 319.8% |
|---|
Top holdings
- Net Receivable / Payable — 71.6%
- National Stock Exchange of India Limited — 9.2%
- Laurus Labs Limited — 8.2%
- Adani Energy Solutions Limited — 4.6%
- Bharat Heavy Electricals Ltd. — 4.5%
- HITACHI ENERGY INDIA LIMITED — 4.2%
- Clearing Corporation of India Ltd — 4.2%
- Divis Laboratories Ltd. — 4.0%
- Solar Industries India Limited — 3.1%
- Multi Commodity Exchange of India Ltd — 3.0%
Top sectors
- Cash — 75.8%
- Pharma & Biotech — 19.4%
- Banking & Financial — 17.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −8.7% | Q3 | #25 of 38 |